Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.

van Zoelen MA, van der Sluijs KF, Achouiti A, Florquin S, Braun-Pater JM, Yang H, Nawroth PP, Tracey KJ, Bierhaus A, van der Poll T.

Virology. 2009 Sep 1;391(2):265-73. doi: 10.1016/j.virol.2009.05.032. Epub 2009 Jul 9.

2.

The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.

van Zoelen MA, Schouten M, de Vos AF, Florquin S, Meijers JC, Nawroth PP, Bierhaus A, van der Poll T.

J Immunol. 2009 Apr 1;182(7):4349-56. doi: 10.4049/jimmunol.0801199.

3.

Receptor for Advanced Glycation End Products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia.

Achouiti A, de Vos AF, van 't Veer C, Florquin S, Tanck MW, Nawroth PP, Bierhaus A, van der Poll T, van Zoelen MA.

PLoS One. 2016 Jan 29;11(1):e0141000. doi: 10.1371/journal.pone.0141000. eCollection 2016.

4.

Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.

Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M.

PLoS Pathog. 2006 Jun;2(6):e53. Epub 2006 Jun 9.

5.

Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Ivanov S, Renneson J, Fontaine J, Barthelemy A, Paget C, Fernandez EM, Blanc F, De Trez C, Van Maele L, Dumoutier L, Huerre MR, Eberl G, Si-Tahar M, Gosset P, Renauld JC, Sirard JC, Faveeuw C, Trottein F.

J Virol. 2013 Jun;87(12):6911-24. doi: 10.1128/JVI.02943-12. Epub 2013 Apr 17.

6.

Receptor for advanced glycation end products is protective during murine tuberculosis.

van Zoelen MA, Wieland CW, van der Windt GJ, Florquin S, Nawroth PP, Bierhaus A, van der Poll T.

Mol Immunol. 2012 Oct;52(3-4):183-9. doi: 10.1016/j.molimm.2012.05.014. Epub 2012 Jun 13.

PMID:
22698798
7.

Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.

Antunes I, Kassiotis G.

J Virol. 2010 Dec;84(24):12564-75. doi: 10.1128/JVI.01559-10. Epub 2010 Oct 13.

8.

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.

Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J, Bialecki E, Pothlichet J, Vendeville C, Barba-Spaeth G, Huerre MR, Faveeuw C, Si-Tahar M, Trottein F.

J Immunol. 2011 May 15;186(10):5590-602. doi: 10.4049/jimmunol.1002348. Epub 2011 Apr 13. Erratum in: J Immunol. 2011 Aug 1;187(3):1515. Barba-Speath, Giovanna [corrected to Barba-Spaeth, Giovanna].

9.

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Brincks EL, Gurung P, Langlois RA, Hemann EA, Legge KL, Griffith TS.

J Immunol. 2011 Nov 1;187(9):4581-8. doi: 10.4049/jimmunol.1002241. Epub 2011 Sep 21.

10.

High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia.

Achouiti A, van der Meer AJ, Florquin S, Yang H, Tracey KJ, van 't Veer C, de Vos AF, van der Poll T.

Crit Care. 2013 Dec 16;17(6):R296. doi: 10.1186/cc13162.

11.

Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia.

Achouiti A, de Vos AF, de Beer R, Florquin S, van 't Veer C, van der Poll T.

J Innate Immun. 2013;5(6):603-12. doi: 10.1159/000348739. Epub 2013 Jun 15.

12.

Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice.

Ramsgaard L, Englert JM, Manni ML, Milutinovic PS, Gefter J, Tobolewski J, Crum L, Coudriet GM, Piganelli J, Zamora R, Vodovotz Y, Enghild JJ, Oury TD.

PLoS One. 2011;6(5):e20132. doi: 10.1371/journal.pone.0020132. Epub 2011 May 23.

13.

17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.

Robinson DP, Hall OJ, Nilles TL, Bream JH, Klein SL.

J Virol. 2014 May;88(9):4711-20. doi: 10.1128/JVI.02081-13. Epub 2014 Feb 12.

14.

Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.

Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR.

J Leukoc Biol. 2004 Oct;76(4):886-95. Epub 2004 Jul 7.

PMID:
15240757
15.

Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.

Stifter SA, Bhattacharyya N, Pillay R, Flórido M, Triccas JA, Britton WJ, Feng CG.

PLoS Pathog. 2016 Jan 5;12(1):e1005378. doi: 10.1371/journal.ppat.1005378. eCollection 2016 Jan.

16.

Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing.

Tadié JM, Bae HB, Banerjee S, Zmijewski JW, Abraham E.

Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C249-56. doi: 10.1152/ajpcell.00302.2011. Epub 2011 Oct 19.

17.

The role of the receptor for advanced glycation end-products in a murine model of silicosis.

Ramsgaard L, Englert JM, Tobolewski J, Tomai L, Fattman CL, Leme AS, Kaynar AM, Shapiro SD, Enghild JJ, Oury TD.

PLoS One. 2010 Mar 19;5(3):e9604. doi: 10.1371/journal.pone.0009604.

18.

Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection.

Kok WL, Denney L, Benam K, Cole S, Clelland C, McMichael AJ, Ho LP.

J Leukoc Biol. 2012 Mar;91(3):357-68. doi: 10.1189/jlb.0411184. Epub 2011 Oct 14.

PMID:
22003207
19.

Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice.

Antoniak S, Tatsumi K, Hisada Y, Milner JJ, Neidich SD, Shaver CM, Pawlinski R, Beck MA, Bastarache JA, Mackman N.

J Thromb Haemost. 2016 Jun;14(6):1238-48. doi: 10.1111/jth.13307. Epub 2016 Apr 5. Erratum in: J Thromb Haemost. 2016 Dec;14 (12 ):2565.

20.

Alveolar Type II Epithelial Cells Contribute to the Anti-Influenza A Virus Response in the Lung by Integrating Pathogen- and Microenvironment-Derived Signals.

Stegemann-Koniszewski S, Jeron A, Gereke M, Geffers R, Kröger A, Gunzer M, Bruder D.

MBio. 2016 May 3;7(3). pii: e00276-16. doi: 10.1128/mBio.00276-16.

Supplemental Content

Support Center